Integrative and multidisciplinary clinical trial using imaging, molecular, and dynamic biomarkers to predict bevacizumab plus chemotherapy response in breast cancer.
J. M. Lopez-Vega
No relevant relationships to disclose
E. G. Calvo
No relevant relationships to disclose
A. Plazaola
No relevant relationships to disclose
B. Hernando
No relevant relationships to disclose
S. Morales Murillo
No relevant relationships to disclose
A. Anton
No relevant relationships to disclose
R. M. S. Gomez
No relevant relationships to disclose
I. Alvarez
No relevant relationships to disclose
J. J. Illarramendi
No relevant relationships to disclose
A. De Juan
No relevant relationships to disclose
P. Martinez
No relevant relationships to disclose
A. Llombart
No relevant relationships to disclose
S. J. Scherer
Employment or Leadership Position - Roche
Consultant or Advisory Role - Roche
Stock Ownership - Roche
Honoraria - Roche
Research Funding - Roche
Expert Testimony - Roche
Other Remuneration - Roche
L. Sabariz
Employment or Leadership Position - Roche
Consultant or Advisory Role - Roche
Stock Ownership - Roche
Honoraria - Roche
Research Funding - Roche
Expert Testimony - Roche
Other Remuneration - Roche
A. la Huerta
No relevant relationships to disclose
L. J. Pina
No relevant relationships to disclose
I. Dominguez
No relevant relationships to disclose
M. J. Garcia Velloso
No relevant relationships to disclose
V. Boni
No relevant relationships to disclose
J. Garcia-Foncillas
No relevant relationships to disclose